AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Studies from C.H. Brothers et al provide new data on HIV/AIDS
June 15th, 2009
"Recently, the Data collection of Adverse events of Anti-HIV Drugs Group (D:A:D) described results from their international observational cohort of 33,347 HIV-1-infected individuals, Suggesting unexpected increased risk of myocardial infarction (MI) associated with abacavir (ABC) therapy [relative rate 1.9, 95% confidence interval (CI): 1.47 to 2.45; P = 0.0001]. To contribute to the scientific question, we summarized GlaxoSmithKline HIV clinical trial data to determine if a similar signal emerged," investigators in Rixensart, Belgium report. "We compiled data from GlaxoSmithKline-sponsored clinical trials with >= 24 weeks of combination antiretroviral therapy...
Source: AIDS Weekly (2009-06-15)
|
